Abstract
Droplet-based single cell platform allows functional screening and sorting of desirable TCR T cells to accelerate development of adoptive T cell therapies.
Funding Information
  • National Institutes of Health (1DP2CA195763)
  • National Institutes of Health (R21CA219225)